EpHA4 abgeleitete Peptid-Impfstoffe

European patent · EP2465864 · Deleted

Register entry

Publication number
EP2465864
Application number
EP12151711
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 21, 2008
Published
Jun 20, 2012
Granted
Oct 8, 2014
Deleted
Feb 28, 2017
Reason
Annual fee unpaid
IPC classes
C07K 14/47 (2006.01)
A61K 39/00 (2006.01)
A61P 35/00 (2006.01)
C07K 14/745 (2006.01)
C12N 5/10 (2006.01)
G01N 33/15 (2006.01)
G01N 33/50 (2006.01)
Priority
US 902949 P 21.02.2007
Divided from
EP08710443
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 20, 2017

    Deleted, fee unpaid

    Published in Swissreg on 20.09.2017

  2. Jul 5, 2016

    Address changed

    Representative
    Vossius & Partner, Nadelberg 3, 4051 Basel → VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB, Nadelberg 3, 4051 Basel

    Published in Swissreg on 05.07.2016

  3. Nov 25, 2014

    Agent entered

    Representative
    Vossius & Partner, Nadelberg 3, 4051 Basel

    Published in Swissreg on 25.11.2014

  4. Oct 8, 2014

    Granted

    Published in Swissreg on 08.10.2014

Parties

Holder

OncoTherapy Science, Inc.

Oncotherapy Science, Inc.

2-1, Sakado 3-chome Takatsu-ku, Kawasaki-shi Kanagawa 213-0012, JP

Agent

Vossius & Partner Patentanwälte Rechtsanwälte mbB

VOSSIUS & PARTNER Patentanwälte Rechtsanwälte mbB

Nadelberg 3, 4051 Basel

Inventor

Tsunoda, Takuya

Kawasaki-shi, Kanagawa 213-0012, JP

Ohsawa, Ryuji

Kawasaki-shi, Kanagawa 213-0012, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.